DePuy Orthopaedics News

The firm is actively filing DePuy ASR lawsuits on behalf of those who allegedly suffered metallosis, premature device failure, or other serious complications related to the 2010 DePuy ASR recall.

The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson and Johnson could be sourcing commercial quantities of poppies outside Tasmania in 2015.

Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.

Assessing whether a stock is a "value play" or a "value trap" has become a popular hobby for financial writers.

In this article, I'm going to show how much Johnson & Johnson stock is worth according to a Warren Buffett "owner earnings" style analysis.

Nanex LLC founder Eric Hunsader presented on High Frequency trading at Wired's Business Conference , and he showed this powerful video of half a second of trading in Johnson & Johnson .

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! A much-anticipated settlement of various federal government probes into Johnson & Johnson marketing of the Risperdal antipsychotic, as well as other medications, is being delayed over language the health care giant fears may cause difficulties for a raft of ... (more)

Medical Device Companies Eke Out Growth In Tough Market, Finds Latest Kalorama Report In the U.S. Medicare, Medicaid, as well as state governments implemented anemic spending increases to hospitals, the key buyer of medical device products.The beginning of 2013 saw the medical device industry make the first payments to the IRS for a new 2.3% ... (more)

The pharmaceutical industry has been subject to a major patent cliff as some of the strongest products lost patent protection.

In a new global study carried out among 412 patient groups from 39 different countries Coloplast is ranked at the very top in front of large international competitors such as Johnson & Johnson and Smith & Nephew.

With the S&P 500 having hit new all-time record highs on Friday, it's a good time to take a look back and see where the index's most recent gains have come from.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson & Johnson may have a new image campaign to help consumers, investors and physicians overlook the cascade of recalls and scandals , but such promotional efforts are no substitute for improved manufacturing procedures.

While there were certainly logical reasons for breaking up the two companies, there was also plenty of doubt because bigger rivals such as Johnson & Johnson had resisted doing the same thing , even though some investors demanded it.

Mark is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Earnings season hasn't been kind to medical-device makers so far. Leading firms in the industry produced mixed results last week, with cardiovascular products in particular crimping sales across the market, despite rising net income at numerous companies.

Greg is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

DePuy Orthopaedics continues to be sued for its Articular Surface Replacement hip replacement, which has attracted lawsuits across the country based on allegations that the metal ball and socket device fails too soon and causes metal to enter patients' bloodstream.

Earnings season hasn't been kind to medical-device makers so far. Leading firms in the industry produced mixed results last week, with cardiovascular products in particular crimping sales across the market, despite rising net income at numerous companies.

Libet Johnson of the Johnson & Johnson clan has gone through some rough times-well, by heiress standards.